Today in Drug Research

Drug Research

Cara out-licenses Korsuva injection ex-US rights to Vifor Fresenius for $520m Cara Therapeutics has granted licensing worldwide rights with the exception of the US, Japan and South Korea to commercialize its Korsuva (CR845/difelikefalin) injection to Vifor Fresenius Medical Care Renal Pharma (VFMCRP). Drug Research > Drug Discovery & Development > News

Latest Drug Research News by Sector

Select a sector from the list or browse by sector below:

Drug Delivery

OptiBiotix Health signs manufacturing and supply deal in India with Akums
OptiBiotix Health has entered into a five year agreement with Akums Drugs and Pharmaceuticals to exclusively manufacture and supply products featuring OptiBiotix's cholesterol and blood pressure reducing strain LPLDL in India.
Drug Research > Drug Delivery > News
AstraZeneca to sell Seroquel drug rights to Luye Pharma for $538m
By PBR Staff Writer
AstraZeneca has agreed to sell the rights to its Seroquel schizophrenia treatment to China-based Luye Phara for $538m.
Drug Research > Drug Delivery > News

Drug Discovery & Development

Malvern Panalytical unveils Zetasizer Pro and Ultra systems
Malvern Panalytical has launched its new Zetasizer Pro and Ultra systems, designed to help in decision-making within crucial analytical workflows associated to product development and quality control.
Production & Manufacturing > Process & Production > News
Epigen to license LPA1 receptor small molecule program to Novo Nordisk
Epigen Biosciences has entered into a collaboration agreement with Novo Nordisk, under which Novo Nordisk has licensed the LPA1 receptor antagonist EPGN696 for development in diabetic and chronic kidney disease and other chronic diseases associated with metabolic syndrome.
Drug Research > Drug Discovery & Development > News